Mergers & Acquisitions

  • August 13, 2025

    Roomba-Maker Execs Sued Over Post-Amazon Deal Issues

    The top brass of iRobot Corp., maker of the Roomba robotic vacuum cleaner, have been hit with a shareholder derivative suit in New York federal court claiming they exaggerated the effectiveness of the company's restructuring plan following the abandonment of a proposed $1.7 billion merger with Amazon.

  • August 13, 2025

    FCC Waives Local Radio Ownership Cap In East Texas

    The Federal Communications Commission will allow an acquisition of several commercial FM radio stations in east Texas to go through by waiving the agency's local ownership cap, the agency said Wednesday.

  • August 13, 2025

    Jewelry Co. Claire's To Appoint UK Insolvency Administrators

    The operator of United Kingdom-based stores of the bankrupt jewelry retailer Claire's said Wednesday it would open an insolvency proceeding and appoint administrators, one week after Claire's filed for Chapter 11 protection in Delaware bankruptcy court.

  • August 13, 2025

    Sapiens Inks $2.5B PE Buyout Deal, With 4 Firms Advising

    Sapiens International, a New Jersey-based software provider for the insurance industry, has agreed to be acquired by private equity firm Advent International in a $2.5 billion all-cash deal, the technology company announced Wednesday.

  • August 13, 2025

    SPAC Behind EV Maker Nikola, Shareholders Strike Settlement

    Stockholders and board members for the blank-check company that took electric-vehicle maker Nikola public said they reached a $6.3 million deal to end a Delaware Chancery Court lawsuit that accused the SPAC of misleading investors about Nikola's prospects.

  • August 13, 2025

    BakerHostetler Hires Cooley Securities Litigation Atty

    BakerHostetler has added an experienced litigator to its white collar, investigations and securities enforcement litigation and securities and governance litigation teams in New York, bringing with him more than 25 years of BigLaw experience, including most recently with Cooley LLP.

  • August 13, 2025

    Simpson Thacher Lands Kirkland M&A Atty In Boston

    Simpson Thacher & Bartlett LLP has brought on a former Kirkland & Ellis LLP partner to its mergers and acquisitions practice in Boston.

  • August 13, 2025

    4 Firms Advise On Gildan's $4.4B Acquisition Of HanesBrands

    Canada's Gildan Activewear Inc. has agreed to acquire HanesBrands for about $2.2 billion, or $4.4 billion including debt, the companies said Wednesday, with four law firms guiding on the cross-border apparel industry deal. 

  • August 13, 2025

    Crypto Co. Bullish Makes Public Debut After Upsized $1B IPO

    Venture-backed crypto exchange Bullish made its public debut Wednesday after raising $1.1 billion in its upsized initial public offering, marking the latest in a string of crypto-related companies to dabble in the public markets.

  • August 13, 2025

    Private Equity Biz's £184M Bid For Energy Adviser To Proceed

    U.S. private equity firm HGGC LLC's £183.6 million ($249 million) bid to acquire the commercial energy and sustainability adviser Inspired PLC can proceed after a rival offer by Regent International Holdings Ltd. failed to secure sufficient support from shareholders.

  • August 12, 2025

    Fanatics Loses Bid For Bar On Boies Schiller In Antitrust Row

    A New York federal judge Tuesday overruled Fanatics Inc.'s objection to an order requiring the sports collectibles company to turn over unredacted versions of licensing agreements to rival Panini America Inc., rejecting Fanatics' bid to place limits on Boies Schiller Flexner LLP attorneys who access the agreements.

  • August 12, 2025

    AstraZeneca, Stockholders Far Apart In Merger Damages Tally

    Syntimmune Inc. stockholders and Alexion Pharmaceuticals have landed tens of millions of dollars apart in new tallies of interest owed after a Court of Chancery ruling in June that Alexion failed a "best efforts" duty to fulfill an autoimmune drug candidate deal.

  • August 12, 2025

    Bayer Bets $1.3B On Kumquat Cancer Drug Candidate

    Pharmaceutical company Bayer and Kumquat Biosciences Inc., a clinical-stage biotech company, on Tuesday announced that they have entered into an exclusive global license and collaboration agreement under which Kumquat will receive up to $1.3 billion to help develop and commercialize its pancreatic cancer-focused drug candidate.

  • August 12, 2025

    FTC Skeptical Of 'Partial' Sale For GTCR Merger Fix

    The Federal Trade Commission told an Illinois federal court that enforcers are reviewing an offer by private equity firm GTCR BC Holding to sell parts of a medical device coatings company in order to fix concerns raised by the company's planned purchase of Surmodics, but said a full sale is preferable.

  • August 12, 2025

    Google Gets $34.5B Chrome Offer Amid Antitrust Fight

    Perplexity AI has submitted a $34.5 billion offer to acquire Google's ubiquitous Chrome web browser, according to a Tuesday term sheet obtained by Law360, as part of a proposed antitrust remedy following ongoing U.S. Department of Justice proceedings against Alphabet Inc.'s Google.

  • August 12, 2025

    Crypto-Focused SPAC Apex Treasury Unveils $250M IPO Plans

    Special purpose acquisition company Apex Treasury Corp. has filed plans for a $250 million initial public offering, with the goal of acquiring a blockchain or crypto treasury company.

  • August 12, 2025

    Petition Seeks FCC Files On Trump-Skydance Meeting

    The head of an artificial intelligence streaming platform called on the Federal Communications Commission to release its findings on his complaint alleging improper lobbying by Skydance Media for its $8 billion merger with Paramount, claiming that Skydance planned an impromptu meeting with President Donald Trump at an April UFC fight.

  • August 12, 2025

    3 Firms Advise As Cardinal Health Makes $1.9B Urology Push

    Cardinal Health said Tuesday that one of its specialty platforms has agreed to acquire a top urology company known as Solaris Health from Lee Equity Partners and Solaris' physician owners for $1.9 billion, in a deal steered by three law firms.

  • August 11, 2025

    2nd Circ. Revives Hezbollah Terrorism Suit Against Bank

    The Second Circuit held Monday that a Lebanese bank is subject to the personal jurisdiction of New York courts on claims over its predecessor's alleged assistance to Hezbollah, citing the state highest court's certified answer in the case while also reasoning that the bank being subjected to the state's jurisdiction was foreseeable.

  • August 11, 2025

    Financiers Want Soccer CEO's SPAC Fraud Suit In England

    An investment business and two other financiers urged a Florida federal court to dismiss a soccer company CEO's lawsuit alleging civil securities fraud in a complex financing deal, saying similar litigation has already been initiated in the United Kingdom. 

  • August 11, 2025

    GTCR Says Sale, Market Nix FTC Med Tech Merger Concerns

    Private equity firm GTCR BC Holdings urged an Illinois federal judge not to block its planned $627 million purchase of a medical device coatings company, arguing in a brief made public Friday that a planned divestiture fully resolves Federal Trade Commission concerns.

  • August 11, 2025

    Hospital Groups Back Challenge Of Merger Notice Overhaul

    A pair of hospital trade associations threw their support behind a U.S. Chamber of Commerce case challenging the Federal Trade Commission's new premerger filing requirements, telling a Texas federal court the agency was wrong to invoke the hospital industry when justifying the changes.

  • August 11, 2025

    What To Watch In Mega Union Pacific-Norfolk Southern Tie-Up

    Union Pacific and Norfolk Southern's bold plan to create the nation's first transcontinental railroad owned by a single firm would transform freight transportation in the U.S., but it must first clear a heightened standard for reviewing mega rail mergers that hasn't yet been tested since the standard was set 24 years ago.

  • August 11, 2025

    DOJ Touts Merger, Rental Algorithm Deals, Eyeing More

    The head of the U.S. Department of Justice's Antitrust Division on Monday touted two recent settlements, in a merger case and in the RealPage algorithmic rent-fixing litigation, as indications that Trump administration enforcers will focus on algorithm-based price-fixing and are willing to "negotiate favorable settlements."

  • August 11, 2025

    Kellogg Sued Over 'Misleading' Statement On $3B Acquisition

    A WK Kellogg shareholder is asking an Illinois federal judge to block The Ferrero Group's $3.1 billion acquisition of the breakfast food company, alleging WK Kellogg and its board of directors submitted an "incomplete and misleading" proxy statement to the U.S. Securities and Exchange Commission to convince shareholders to support the transaction.

Expert Analysis

  • Building Better Earnouts In The Current M&A Climate

    Author Photo

    In the face of market uncertainty, we've seen a continued reliance on earnouts in M&A deals so far this year, but to reduce the risk of related litigation, it's important to use objective standards, apply company metrics cautiously and ensure short time periods, among other best practices, say attorneys at White & Case.

  • Series

    Law School's Missed Lessons: Skillful Persuasion

    Author Photo

    In many ways, law school teaches us how to argue, but when the ultimate goal is to get your client what they want, being persuasive through preparation and humility is the more likely key to success, says Michael Friedland at Friedland Cianfrani.

  • A Look At Trump 2.0 Antitrust Enforcement So Far

    Author Photo

    The first six months of President Donald Trump's second administration were marked by aggressive antitrust enforcement tempered by traditional structural remedies for mergers, but other unprecedented actions, like the firing of Federal Trade Commission Democrats, will likely stoke heated discussion ahead, says Richard Dagen at Axinn.

  • Litigation Inspiration: How To Respond After A Loss

    Author Photo

    Every litigator loses a case now and then, and the sting of that loss can become a medicine that strengthens or a poison that corrodes, depending on how the attorney responds, says Bennett Rawicki at Hilgers Graben.

  • The Metamorphosis Of The Major Questions Doctrine

    Author Photo

    The so-called major questions doctrine arose as a counterweight to Chevron deference over the past few decades, but invocations of the doctrine have persisted in the year since Chevron was overturned, suggesting it still has a role to play in reining in agency overreach, say attorneys at Crowell & Moring.

  • Biotech Collaborations Can Ease Uncertainty Amid FDA Shift

    Author Photo

    As concerns persist that the U.S. Food and Drug Administration's reduced headcount will impede developments at already-strapped biotech companies, licensing and partnership transactions can provide the necessary funding and pathways to advance innovative products, say attorneys at Troutman.

  • Series

    Playing Mah-Jongg Makes Me A Better Mediator

    Author Photo

    Mah-jongg rewards patience, pattern recognition, adaptability and keen observation, all skills that are invaluable to my role as a mediator, and to all mediating parties, says Marina Corodemus.

  • Business Court Bill Furthers Texas' Pro-Corporate Strategy

    Author Photo

    The Texas Legislature's recent bill to enhance corporate protections and expand access to the Texas Business Court by refining its jurisdictional standards is just the latest step in the state's playbook for becoming the new center of corporate America, say attorneys at Katten.

  • FTC Staff Cuts Unlikely To Curb Antitrust Enforcement Agenda

    Author Photo

    While Federal Trade Commission Chair Andrew Ferguson's recent commitment to reducing agency staff may seem at odds with the Trump administration's commitment to antitrust enforcement, a closer analysis shows that such reductions have little chance of derailing the president's efforts, say attorneys at Squire Patton.

  • Series

    Law School's Missed Lessons: Navigating Client Trauma

    Author Photo

    Law schools don't train students to handle repeated exposure to clients' traumatic experiences, but for litigators practicing in areas like civil rights and personal injury, success depends on the ability to view cases clinically and to recognize when you may need to seek help, says Katie Bennett at Robins Kaplan.

  • Opinion

    4 Former Justices Would Likely Frown On Litigation Funding

    Author Photo

    As courts increasingly confront cases involving hidden litigation finance contracts, the jurisprudence of four former U.S. Supreme Court justices establishes a constitutional framework that risks erosion by undisclosed financial interests, says Roland Eisenhuth at the American Property Casualty Insurance Association.

  • Takeaways From EU's Review Of Merger Control Guidelines

    Author Photo

    The European Commission’s newly launched consultation on the European Union’s merger guidelines will explore whether and how merger control should consider key policy objectives, such as innovation, investment incentives and security, say lawyers at Latham.

  • How Attys Can Use AI To Surface Narratives In E-Discovery

    Author Photo

    E-discovery has reached a turning point where document review is no longer just about procedural tasks like identifying relevance and redacting privilege — rather, generative artificial intelligence tools now allow attorneys to draw connections, extract meaning and tell a coherent story, says Rose Jones at Hilgers Graben.

  • Identifying Data Center Investment Challenges, Opportunities

    Author Photo

    The role of data centers is expanding, as are new opportunities for private capital investors, but there are issues to consider, including finance models and contract complexity, as well as power supply, cyber threat resilience and data sovereignty, say lawyers at Ropes & Gray.

  • Leveraging Diligence Findings For Better Life Sciences Deals

    Author Photo

    Life sciences parties should utilize due diligence strategically to review and draft deal documents, address issues identified during the diligence, and craft solutions to achieve the party's transactional goals, says Anna Zhao at Gunner Cooke.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.